Compare BGC & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BGC | CAI |
|---|---|---|
| Founded | 1945 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 6.2B |
| IPO Year | 1999 | 2025 |
| Metric | BGC | CAI |
|---|---|---|
| Price | $12.14 | $24.46 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $30.91 |
| AVG Volume (30 Days) | 2.5M | ★ 4.5M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.72% | N/A |
| EPS Growth | 24.00 | ★ 69.79 |
| EPS | ★ 0.31 | N/A |
| Revenue | ★ $2,941,460,000.00 | $812,033,000.00 |
| Revenue This Year | $22.26 | $25.24 |
| Revenue Next Year | $7.03 | $22.32 |
| P/E Ratio | $39.32 | ★ N/A |
| Revenue Growth | 29.99 | ★ 96.97 |
| 52 Week Low | $8.27 | $14.19 |
| 52 Week High | $12.89 | $34.54 |
| Indicator | BGC | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 61.79 | 53.42 |
| Support Level | $11.59 | $17.15 |
| Resistance Level | $12.35 | $28.88 |
| Average True Range (ATR) | 0.37 | 1.36 |
| MACD | 0.04 | -0.44 |
| Stochastic Oscillator | 89.34 | 12.21 |
BGC Group Inc is a brokerage and financial technology company that serves financial markets, energy, and commodities markets. Its service and product offerings include brokerage for a wide range of financial products, including fixed income, equities, commodities, derivatives, and real estate, software solutions for trading platforms, clearing, trade execution, and other back-office services. Its clients mostly include banks, financial institutions, and corporate clients. BGC operates in one reportable segment, which is providing brokerage services. Geographically, the company generates a majority of its revenue from Europe, the Middle East and Africa (EMEA), followed by the Americas and the Asia-Pacific region.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.